Epilepsy & Seizures

Filter Your Results




Gene Delivery Into Ependymal Cells Lining Ventricles for Batten’s Disease

Monday, March 25, 2019—As genetic therapy for neurologic diseases moves toward the mainstream, a key challenge that must be addressed is the need to deliver genes to the central nervous system (CNS)…

Epilepsy Foundation Promotes Proper First Aid for Seizures

Tuesday, March 05, 2019—The Epilepsy Foundation has launched a series of public service announcements (PSAs) in an initiative to improve about seizure recognition and awareness of proper first aid.&n…

Expanded Access to Free Genetic Testing for Children with Epilepsy

Wednesday, February 27, 2019—Eligibility for a program that provides free genetic testing for epilepsy in young children has been expanded. The Behind the Seizure program, which had been available for pat…

Scalp Neurostimulation Reduces Seizure Activity in Drug-Resistant Epilepsy

Tuesday, February 26, 2019—A device that uses mild electrical currents on the scalp achieved positive results for treating patients with drug-resistant epilepsy. In an investigational study (NCT02866240…

Deep Brain Stimulator for Medically-Refractory Epilepsy Now Available in US

Wednesday, February 20, 2019—Deep brain stimulation (DBS) with the Medtronic DBS System (Medtronic, Dublin, Ireland) was approved by the Food and Drug Administration (FDA) last year and is now available i…

New CPT Code for Electrocorticography From Responsive Neurostimulator

Wednesday, February 13, 2019—The American Medical Association (AMA) has issued a new Category/Current Procedural Terminology (CPT) code for electrocorticography from an implanted brain neurostimulato…

Durable Benefit from Treating Batten’s Disease with Cerliponase Alfa

Monday, February 11, 2019—In an ongoing, open-label extension study of cerliponase alfa (Brineura; BioMarin, San Rafael, CA) for treatment of patients with late infantile neuronal ceroid lipofuscinosis…

New Drug Application for Cenobamate to Treat Epilepsy Accepted

Friday, February 08, 2019—The Food and Drug Administration (FDA) has accepted the new drug application (NDA) filing for cenobamate (SK life science; Fair Lawn, NJ), an investigational antiepileptic dru…


Contact Info

For advertising rates and opportunities:
Wendy Terry

About Practical Neurology

Launched in 2002, Practical Neurology is a publication uniquely dedicated to presenting current approaches to patient management, synthesis of emerging research and data, and analysis of industry news with a goal to facilitate practical application and improved clinical practice for all neurologists. Our straightforward articles give neurologists tools they can immediately put into practice.